{"data":{"id":1228,"lang":"en","title":"Trump Prepares 100% Tariff on Imported Branded Drugs, Offers Onshoring Deal to Pharma Giants","summary":"Trump administration to impose 100% tariff on branded drug imports under Section 232, with a 20% rate for companies that commit to US onshoring.","category":"business","category_label":"Business","published_at":"2026-04-02T19:12:25Z","updated_at":"2026-04-02T19:12:25Z","url":"https://techtools.cz/tools/news/article/1228-trump-prepares-100-tariff-on-imported-branded-drugs-offers-onshoring-deal-to","api_url":"https://techtools.cz/news-api/v1/articles/1228?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/1228.md?lang=en","image_url":"https://www.statnews.com/wp-content/uploads/2025/07/GettyImages-2208880191.jpg","word_count":171,"reading_time_minutes":1,"sources":[{"url":"https://www.statnews.com/2026/04/01/trump-section-232-tariffs-imported-brand-drugs/","domain":"statnews.com"},{"url":"https://www.cnn.com/2026/04/02/politics/tariffs-trump-pharmaceutical-drugs","domain":"cnn.com"},{"url":"https://www.cnbc.com/2026/04/02/trump-pharmaceutical-tariffs-100percent.html","domain":"cnbc.com"}],"translation":{"lang":"cs","id":1279,"title":"Trump chystá 100% clo na dovážené značkové léky, farmaceutickým gigantům nabízí dohodu o přesunu výroby do USA","url":"https://techtools.cz/tools/news/clanek/1279-trump-chysta-100-clo-na-dovazene-znackove-leky-farmaceutickym-gigantum-nabizi","api_url":"https://techtools.cz/news-api/v1/articles/1279?lang=cs"},"content":"The Trump administration is set to impose a 100% tariff on imports of patented medications and their active ingredients under Section 232 of the Trade Expansion Act. Generic drugs would face zero additional tariffs. The order provides a pathway for drugmakers to cut the rate to 20% for four years if they commit to moving production to the US, though the full 100% tariff would kick back in by 2030.\n\nSeveral major drugmakers have already struck deals to avoid the levies. Pfizer and AstraZeneca secured multi-year exemptions through pricing agreements on the new TrumpRx.gov platform, while Eli Lilly, Johnson \u0026 Johnson, and Merck pledged significant investments to expand US manufacturing. The plans are not yet final and may include exemptions for certain medicines and disease categories.\n\nThe announcement, expected as early as Thursday, marks the most aggressive use of trade policy to reshape pharmaceutical supply chains. With most branded drugs manufactured overseas, the tariffs could affect drug prices for millions of Americans if companies choose to pass costs on rather than relocate."}}